Soleno Therapeutics logo

Soleno Therapeutics Share Price (NASDAQ: SLNO)

$67.67

-0.74

(-1.08%)

Last updated on

Check the interactive Soleno Therapeutics Stock chart to analyse performance

Soleno Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$67.09
    Today's High:$68.06

    Day's Volatility :1.43%

  • 52 Weeks Low:$41.50
    52 Weeks High:$90.32

    52 Weeks Volatility :54.05%

Soleno Therapeutics Stock Returns

PeriodSoleno Therapeutics IncIndex (Russel 2000)
3 Months
-10.6%
0.0%
6 Months
47.69%
0.0%
1 Year
43.09%
0.0%
3 Years
2919.64%
-4.7%

Soleno Therapeutics Inc Key Stats

Check Soleno Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$68.41
Open
$67.98
Today's High
$68.06
Today's Low
$67.09
Market Capitalization
$3.6B
Today's Volume
$923.3K
52 Week High
$90.3199
52 Week Low
$41.5
Revenue TTM
$32.7M
EBITDA
$-184.3M
Earnings Per Share (EPS)
$-4.27
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-69.53%

Stock Returns calculator for Soleno Therapeutics Stock including INR - Dollar returns

The Soleno Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Soleno Therapeutics investment value today

Current value as on today

₹1,48,440

Returns

₹48,440

(+48.44%)

Returns from Soleno Therapeutics Stock

₹43,156 (+43.16%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Soleno Therapeutics Stock

-13%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Soleno Therapeutics Stock from India on INDmoney has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Soleno Therapeutics Inc

  • Name

    Holdings %

  • HHG PLC

    9.99%

  • Vivo Capital, LLC

    8.39%

  • Adage Capital Partners Gp LLC

    8.27%

  • T. Rowe Price Associates, Inc.

    6.51%

  • Vanguard Group Inc

    4.68%

  • FMR Inc

    4.20%

Analyst Recommendation on Soleno Therapeutics Stock

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Soleno Therapeutics(by analysts ranked 0 to 5 stars)

Soleno Therapeutics Share Price Target

What analysts predicted

Upside of 75.26%

Target:

$118.60

Current:

$67.67

Soleno Therapeutics share price target is $118.60, a slight Upside of 75.26% compared to current price of $67.67 as per analysts' prediction.

Soleno Therapeutics Stock Insights

  • Price Movement

    In the last 3 years, SLNO stock has moved up by 3017.1%
  • SLNO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 31.7%
  • Price to Sales

    ForSLNO every $1 of sales, investors are willing to pay $94.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Soleno Therapeutics Technicals Summary

Sell

Neutral

Buy

Soleno Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Soleno Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Soleno Therapeutics Inc logo
-21.35%
47.69%
43.09%
2919.64%
119.97%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Soleno Therapeutics Inc

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
Organization
Soleno Therapeutics
Employees
133
CEO
Dr. Anish Bhatnagar M.D.
Industry
Health Technology

Key Management of Soleno Therapeutics Inc

NameTitle
Dr. Anish Bhatnagar M.D.
Chairman, President, CEO & COO
Mr. James H. MacKaness
CFO & Compliance Officer
Ms. Patricia C. Hirano M.P.H.
Senior Vice President of Regulatory Affairs
Ms. Meredith Manning M.B.A.
Chief Commercial Officer
Mr. Jesse Schumaker
General Counsel
Ms. Lauren Budesheim
Senior Vice President of People
Ms. Kristen Yen M.S.
Senior Vice President of Global Clinical Operations and Patient Advocacy
Dr. Neil M. Cowen M.B.A., Ph.D.
Senior Vice President of Drug Development
Dr. Michael Huang M.D.
Senior Vice President of Clinical Development
Dr. Mitchell Nagao M.B.A., Pharm.D.
Senior Vice President of Medical Affairs

Important FAQs about investing in SLNO Stock from India :

What is Soleno Therapeutics share price today?

Soleno Therapeutics share price today is $67.67 as on at the close of the market. Soleno Therapeutics share today touched a day high of $68.06 and a low of $67.09.

What is the 52 week high and 52 week low for Soleno Therapeutics share?

Soleno Therapeutics share touched a 52 week high of $90.32 and a 52 week low of $41.50. Soleno Therapeutics stock price today i.e. is closed at $67.67, lower by 25.08% versus the 52 week high.

How to invest in Soleno Therapeutics Stock (SLNO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Soleno Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Soleno Therapeutics Shares that will get you 0.0222 shares as per Soleno Therapeutics share price of $67.67 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Soleno Therapeutics Stock (SLNO) from India?

Indian investors can start investing in Soleno Therapeutics (SLNO) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Soleno Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Soleno Therapeutics share’s latest price of $67.67 as on August 30, 2025 at 1:29 am IST, you will get 0.1478 shares of Soleno Therapeutics. Learn more about fractional shares .

What are the returns that Soleno Therapeutics has given to Indian investors in the last 5 years?

Soleno Therapeutics stock has given 119.97% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?